Skip to main content

Dairy Alternatives Market to Transcend USD 66.88 Billion by 2031 | SkyQuest

Westford, USA, Aug. 27, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that Global Dairy Alternatives Market will attain a value of USD 66.88 Billion by 2031, with a CAGR of 12.5% over the forecast period (2024-2031). Dairy substitutes have gained a lot of traction in both established and developing markets. This is explained by the increase in the number of dairy allergy sufferers. Furthermore, the market for dairy substitutes has grown because of rising disposable income and health consciousness. The addition of new, healthful components by various market participants is another aspect that propels the industry’s expansion. Download a detailed overview: https://www.skyquestt.com/sample-request/dairy-alternatives-market Browse in-depth TOC on the ” Dairy Alternatives Market “Pages – 157 Tables – 124 Figures...

Continue reading

Archrock Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Acquisition of Total Operations and Production Services, LLC

HOUSTON, Aug. 27, 2024 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE: AROC) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”), in connection with its pending acquisition of Total Operations and Production Services, LLC. The expiration of the waiting period under the HSR Act satisfies an important condition necessary for the completion of the transaction. The transaction is expected to close in the third quarter of 2024 subject to the satisfaction of other customary closing conditions. About Archrock Archrock is an energy infrastructure company with a primary focus on midstream natural gas compression and a commitment to helping its customers produce, compress and transport natural gas in a safe and environmentally responsible way. Headquartered...

Continue reading

Form 8.3 – [ECKOH PLC – 23 08 2024] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ECKOH PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Smart for Life Provides Update on Prospective Acquisitions

Multiple Acquisitions in Pipeline; Ranging from Definitive Agreement to Exploratory Discussions as Phase 2 of the Company’s Post-Restructuring Initiatives; Company Provides Update on Timing for Form 10-Q MIAMI, Aug. 26, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today provided an update on the potential expansion of the Company’s acquisition pipeline and an update on its M&A activities. Currently, the Company is negotiating four profitable Health & Wellness acquisitions and exploring additional prospects as part of its post-restructuring strategy. These targets include Purely Optimal Nutrition, a liquid manufacturer, an established...

Continue reading

Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.

Agile Therapeutics has combined with Insud Pharma’s US Subsidiary, Exeltis USA, Inc., expanding an already significant women’s health/contraceptive portfolio Agile Therapeutics Common Shareholders to receive $1.52 per share of common stock Agile common stock will cease to be listed on the OTC QB PRINCETON, N.J., Aug. 26, 2024 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (“Agile”) (OTCQB: AGRX), a women’s healthcare company, today announced the completion of the acquisition of Agile by Insud Pharma, S.L. (“Insud”) a global pharmaceutical group based in Spain with a 45-year track record and a presence in over 50 countries. The former holders of Agile common stock voted to approve the acquisition at a special meeting of stockholders on August 22, 2024. Upon closing of the acquisition, former shareholders of Agile became entitled...

Continue reading

Healthcare Realty Trust Expands KKR Joint Venture

KKR JV approaching $500 million in value with new asset contributions NASHVILLE, Tenn., Aug. 26, 2024 (GLOBE NEWSWIRE) — Healthcare Realty Trust Incorporated (NYSE:HR) today announced it has contributed $118 million of additional properties to its joint venture with KKR, generating approximately $94 million of proceeds. The value of the JV is now approaching $500 million. The Company and KKR are continuing to explore additional acquisitions for the JV, including the potential contribution of more Healthcare Realty properties. As previously disclosed in July, the Company also has additional asset sales and JV transactions under contract or LOI that are expected to increase proceeds to over $1 billion. The majority of these transactions are expected to be completed in the third quarter, with proceeds expected to fund accretive, leverage...

Continue reading

Advanced Analytics Market Growth at USD 480.99 Billion by 2031 | SkyQuest

Westford, USA, Aug. 26, 2024 (GLOBE NEWSWIRE) — Global Advanced Analytics Market size was valued at around USD 41.85 billion in 2022 and is expected to rise from USD 64.3 billion in 2023 to reach a value of USD 480.99 Billion by 2031, at a CAGR of 28.6% during the forecast period (2024–2031). Download a detailed overview: https://www.skyquestt.com/sample-request/advanced-analytics-market The growth of the advanced analytics market is increasing due to high usage of computer learning and artificial intelligence to offer personalized consumer experiences along with rising popularity of online shopping. The extensive adoption of social networking platforms is another factor, propelling the market’s expansion. Recently, the data collected by organizations have increased massively, they collect the data and analyze it to get valuable...

Continue reading

Smart Buildings Market to Grow at 11% CAGR by 2031 |SkyQuest: Driven by High Demand of Digitalization in Buildings to Improve Safety

Westford, USA, Aug. 26, 2024 (GLOBE NEWSWIRE) — Global Smart Buildings Market size was valued at USD 80.25 billion in 2022 and is poised to grow from USD 89.08 billion in 2023 to USD 205.3 billion by 2031, growing at a CAGR of 11% in the forecast period (2024-2031). Download a detailed overview: https://www.skyquestt.com/sample-request/smart-building-market Smart buildings used technology to streamline complicated things so that it becomes easier to maintain and is safe. The rising trend of smart cities also plays a crucial part in developing new opportunities for the smart building market. With the advancement of digital technologies, sensors, and telecommunications, it has become easier to monitor and control buildings more efficiently than before. Smart buildings highly depend on various types of IoT sensors and computer networks...

Continue reading

UFP Technologies Acquires AQF Medical

NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) — UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited (“AQF Medical”). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. “We are excited about the addition of AQF Medical, our fourth acquisition in the past few months,” said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies. “AQF Medical, with their excellent leadership team and strong reputation, brings significant value to our MedTech platform. Their expertise in...

Continue reading

Life Science Analytics Market Growth at USD 70.10 Billion by 2031 | SkyQuest

Westford, USA, Aug. 26, 2024 (GLOBE NEWSWIRE) — Global Life Science Analytics Market size was valued at 26.80 USD Billion in 2022 and is poised to grow from USD 29.86 Billion in 2023 to USD 70.10 Billion by 2031, at a CAGR of 11.4 % during the forecast period (2024-2031).  Download a detailed overview: https://www.skyquestt.com/sample-request/life-science-analytics-market One of the major driving factors that promotes the development of the life science analytics market is the technical upgradation in the field of analytics in healthcare segment. Moreover, the increasing incorporation of big data in medical sectors is also one of the primary factors that is leading the life science analytics market towards progression. Life science analytics contains descriptive, predictive, and prescriptive analytics. These analytics utilize...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.